Telemus Capital’s iShares Biotechnology ETF IBB Stock Holding History

Telemus Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,000	Closed	-$335K	–	395
2019 Q1	$335K	Hold	3,000	–	–	0.03%	319
2018 Q4	$289K	Sell	3,000 -6,000	-67%	-$637K	0.02%	329
2018 Q3	$1.1M	Hold	9,000	–	–	0.08%	187
2018 Q2	$988K	Sell	9,000 -2,025	-18%	-$217K	0.08%	207
2018 Q1	$1.18M	Hold	11,025	–	–	0.09%	179
2017 Q4	$1.18M	Buy	11,025 +2,025	+23%	+$216K	0.09%	185
2017 Q3	$1M	Sell	9,000 -2,025	-18%	-$216K	0.11%	132
2017 Q2	$1.14M	Buy	+11,025	New	+$1.09M	0.12%	144
2017 Q1	–	Sell	-8,028	Closed	-$710K	–	344
2016 Q4	$710K	Buy	+8,028	New	+$731K	0.1%	163

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Telemus Capital's IBB Position: Q2 2019 in Review

Telemus Capital sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 3,000 shares — an estimated $335K sold.

Telemus Capital first reported a position in IBB in Q4 2016 and held it in 9 quarters. The position peaked at $1.18M in Q1 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Telemus Capital reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Telemus Capital sold 3,000 iShares Biotechnology ETF shares in Q2 2019, an estimated $335K.
Telemus Capital first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 9 quarters.
Telemus Capital's iShares Biotechnology ETF position peaked at $1.18M in Q1 2018.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Telemus Capital's 13F filing for Q2 2019, filed 9 Aug 2019.